Showing results (611-620 of 760) with videos related to

Sort By:
Pageof 76
Antimicrobial Agents and Chemotherapy|June 6, 2012
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosisIan M Rosenthal, Rokeya Tasneen, Charles A Peloquin, et al.
Lancet (London, England)|July 30, 1994
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyB Heym, N Honoré, C Truffot-Pernot, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2013
Assessment of clofazimine activity in a second-line regimen for tuberculosis in miceJacques H Grosset, Sandeep Tyagi, Deepak V Almeida, et al.
Lancet (London, England)|September 12, 2001
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreakP Astagneau, N Desplaces, V Vincent, et al.
NPJ Parkinson'S Disease|September 25, 2021
Optimising classification of Parkinson's disease based on motor, olfactory, neuropsychiatric and sleep featuresJonathan P Bestwick, Stephen D Auger, Anette E Schrag, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
A blind study of the polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA. Azay Mycobacteria Study GroupF Doucet-Populaire, V Lalande, E Carpentier, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigsNoton K Dutta, Peter B Illei, Charles A Peloquin, et al.
Pageof 76